Business
Viveve(R) Announces Entrance Into Latin America With Brazil Distribution Partnership
Viveve(R) Announces Entrance Into Latin America With Brazil Distribution Partnership.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Announces Entrance Into Latin America With Brazil Distribution Partnership \n\nViveve(R) Announces Entrance Into Latin America With Brazil Distribution Partnership\n\n\nViveve System -- Non-Surgical Treatment for Vaginal Laxity -- Now Available in 51 Countries Throughout the World \n\n\n SUNNYVALE, CA--(Marketwired - March 08, 2016) - Viveve Medical, Inc. (\"Viveve\") (OTCQB: VIVMF), a company focused on women's health, today announced the expansion of its commercial availability into Latin America through a distribution partnership with HV Medical, an esteemed supplier of medical products headquartered in São Paulo, Brazil. Under the terms of the agreement HV Medical will have distribution rights for the Viveve System throughout Brazil. \"We're excited about entering the Latin American market, particularly in Brazil, which is the largest market for aesthetic medical procedures in the world. This relationship represents a significant expansion of our rapidly growing global commercialization effort,\" said Patricia Scheller, chief executive officer of Viveve. \"The combination of our technology with HV Medical's extensive experience in Brazil will pave the way for widespread availability of the Viveve Treatment while also ensuring that physicians receive the best possible training and ongoing support as they begin offering the only clinically proven, non-surgical treatment for vaginal laxity.\"HV Medical, a distributor of innovative medical technologies and products, has established an excellent reputation in Brazil. With an extensive range of high quality products and services, HV Medical delivers complete solutions and customized treatments to physicians and medical facilities. \"We are happy to be able to add the Viveve System, a safe and clinically proven device to our portfolio,\" said Newton Martins, vice president of HV Medical. \"Vaginal laxity is a common and troublesome condition for women, and the fact that there is now an effective non-surgical approach, involving just one pain-free out-patient procedure, will be welcome news to physicians and their patients.\" Viveve now has 17 exclusive partnerships covering distribution of the Viveve System in 51 countries around the world, with regulatory clearance for the technology in 22 of those countries:\n \n \n GEOGRAPHIC R...